Perinatal Medicine, Royal Maternity Hospital, and Department of Child Health, Queen's University Belfast, Belfast, Northern Ireland.
Best Pract Res Clin Obstet Gynaecol. 2009 Dec;23(6):871-80. doi: 10.1016/j.bpobgyn.2009.06.005. Epub 2009 Jul 26.
Intrauterine or fetal growth restriction is best defined by using customised birth weight percentiles based upon the growth potential for an individual infant. Growth restriction in utero may be classified as asymmetric or symmetric depending upon the duration of the process. Asymmetric growth restriction is caused by placental insufficiency, maternal hypertensive conditions, long-standing maternal diabetes, smoking, living at altitude or multiple gestation. Symmetric growth restriction may be due to congenital infections, chromosomal or other abnormalities, fetal alcohol syndrome, low socioeconomic status or be constitutional. The underlying cause of growth restriction often predicts the potential adverse effects on the foetus and newborn and later effects in childhood and adulthood. With placental insufficiency, there may be chronic or acute on chronic fetal hypoxia with birth asphyxia and hypothermia, neonatal hypoglycaemia, polycythaemia and coagulopathy. Management is directed at prevention or early treatment of these conditions. In contrast, symmetrically growth-restricted infants should be examined carefully to look for congenital infections and malformations that may need specific interventions. Infants with constitutional short stature generally do not need any specific management. Feeding of growth-restricted infants is important to overcome deficiencies incurred in utero. Most infants show catch-up growth although about 10% do not. Those with excessive catch-up growth may be at greatest risk of developing insulin resistance in adulthood leading to diabetes, obesity and heart disease. The so-called fetal origins of disease may actually have a postnatal onset related more to excessive weight gain in infancy. There is still controversy over the indications for growth hormone treatment in growth-restricted infants who remain of short stature in early childhood. Intrauterine growth restriction is also associated with a five- to seven-fold increased risk of cerebral palsy probably due to chronic placental insufficiency.
胎儿宫内生长受限最好通过使用基于个体婴儿生长潜力的定制出生体重百分位来定义。根据该过程的持续时间,宫内生长受限可分为不对称或对称。不对称性生长受限是由胎盘功能不全、母体高血压疾病、长期母体糖尿病、吸烟、高海拔居住或多胎妊娠引起的。对称性生长受限可能是由先天性感染、染色体或其他异常、胎儿酒精综合征、低社会经济地位或先天性引起的。生长受限的根本原因通常可以预测对胎儿和新生儿的潜在不利影响,以及儿童期和成年期的后期影响。在胎盘功能不全的情况下,可能会出现慢性或慢性胎儿缺氧,伴有出生窒息和低体温、新生儿低血糖、红细胞增多症和凝血功能障碍。治疗的重点是预防或早期治疗这些疾病。相反,对称性生长受限的婴儿应仔细检查,以寻找可能需要特定干预的先天性感染和畸形。先天性身材矮小的婴儿通常不需要任何特定的治疗。喂养生长受限的婴儿对于克服宫内发生的缺陷很重要。大多数婴儿会出现追赶生长,尽管约有 10%的婴儿不会。那些追赶生长过度的婴儿可能面临最大的风险,在成年后患胰岛素抵抗,导致糖尿病、肥胖和心脏病。所谓的疾病的胎儿起源实际上可能在出生后与婴儿期过度体重增加有关。对于在幼儿期仍身材矮小的生长受限婴儿,生长激素治疗的适应症仍存在争议。胎儿宫内生长受限也与脑瘫的风险增加五到七倍有关,这可能是由于慢性胎盘功能不全所致。